Synergistic activity of sorafenib and betulinic acid against clonogenic activity of non‐small cell lung cancer cells

The highly selective multi‐targeted agent sorafenib is an inhibitor of a number of intracellular signaling kinases with anti‐proliferative, anti‐angiogenic and pro‐apoptotic effects in various types of tumors, including human non‐small cell lung cancer (NSCLC). Betulin displays a broad spectrum of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutkowska, Justyna, Strzadala, Leon, Rapak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666031/
https://www.ncbi.nlm.nih.gov/pubmed/28846180
http://dx.doi.org/10.1111/cas.13386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666031/
https://www.ncbi.nlm.nih.gov/pubmed/28846180
http://dx.doi.org/10.1111/cas.13386

Ejemplares similares